Larson Financial Group’s Integra LifeSciences IART Stock Holding History

Larson Financial Group’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$216	Buy	+12	New	+$168	﹤0.01%	3596
2025 Q2	–	Sell	-628	Closed	-$13.8K	–	3387
2025 Q1	$13.8K	Hold	628	–	–	﹤0.01%	1512
2024 Q4	$14.2K	Buy	628 +6	+1%	+$131	﹤0.01%	1348
2024 Q3	$11.3K	Buy	+622	New	+$14.4K	﹤0.01%	1434
2023 Q2	–	Sell	-100	Closed	-$5.74K	–	1601
2023 Q1	$5.74K	Hold	100	–	–	﹤0.01%	1059
2022 Q4	$5.61K	Hold	100	–	–	﹤0.01%	1001
2022 Q3	$4K	Buy	+100	New	+$5.12K	﹤0.01%	994

Other funds holding IART

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Larson Financial Group's IART Position: Q2 2026 in Review

Larson Financial Group opened a new position in Integra LifeSciences (IART) in Q2 2026: 12 shares worth $216. The stake represents ﹤0.01% of the portfolio and ranks #3596 among its holdings. This is a return to the name: Larson Financial Group previously reported a position in IART as recently as Q1 2025.

Larson Financial Group first reported a position in IART in Q3 2022 and has held it in 7 quarters since. The position peaked at $14.2K in Q4 2024. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

Larson Financial Group held 12 shares of Integra LifeSciences worth $216 as of Q2 2026.
Integra LifeSciences was a new Larson Financial Group position in Q2 2026.
Integra LifeSciences made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #3596 holding.
Larson Financial Group first reported a position in Integra LifeSciences in Q3 2022 and has held it in 7 quarters since.
Larson Financial Group's Integra LifeSciences position peaked at $14.2K in Q4 2024.
212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.